Neuron23

South San Francisco, CA · Founded 2018 · Privately Held (backing)

Developer of an artificial intelligence-based drug discovery model designed for genetically defined neurological and immunological diseases. Neuron23 is based in South San Francisco, CA and was founded in 2018. Its last reported valuation was $272 million in Jun 2025. It has raised $310 million.

Last reported valuation

$271.5M

Oct 2026

Priced at

—

Total raised

$310.0M

Last round

—

How much has Neuron23 raised?

$310.0Macross 0 recorded rounds

Free account

More of Neuron23 with a free account

·The complete investor list: 14 names
·Watch Neuron23: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Neuron23 investors

14 investors are on record for Neuron23, including SoftBank Investment Advisers, Kleiner Perkins, Blue Owl Capital and Perceptive Advisors. By type, the record holds 3 hedge funds and 2 venture capital firms.

For fundraisers

Raising for a company like Neuron23?

14 investors have backed Neuron23.

See all 14 investors →

Frequently asked about Neuron23

How much has Neuron23 raised?: Neuron23 has raised $310.0M in total across 0 recorded funding rounds.